Supplemental material
Open access
1,164
Views
0
CrossRef citations to date
0
Altmetric
Oncology
A real-world, retrospective, observational study examining treatment patterns and clinical outcomes in patients with FLT3m + AML in Japan
Toru Kiguchia Dokkyo Medical University Saitama Medical Center, Saitama, Japan
, Masaya Sakuraib Astellas Pharma Inc., Tokyo, JapanCorrespondence[email protected]
, Yusuke Tanakab Astellas Pharma Inc., Tokyo, Japan
, Kazuyuki Kuramotob Astellas Pharma Inc., Tokyo, Japan
, Yuki Kadoc IQVIA Solutions Japan K.K., Tokyo, Japan
, Sono Sawadac IQVIA Solutions Japan K.K., Tokyo, Japan
& Takeshi Mitomib Astellas Pharma Inc., Tokyo, Japan
show all
Pages 1513-1522
|
Received 30 Jun 2023, Accepted 12 Oct 2023, Published online: 02 Nov 2023
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.